Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Total Liabilities (2019 - 2025)

Pulmonx has reported Total Liabilities over the past 7 years, most recently at $75.2 million for Q4 2025.

  • Quarterly Total Liabilities fell 2.42% to $75.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $75.2 million through Dec 2025, down 2.42% year-over-year, with the annual reading at $75.2 million for FY2025, 2.42% down from the prior year.
  • Total Liabilities was $75.2 million for Q4 2025 at Pulmonx, down from $78.2 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $78.2 million in Q3 2025 and troughed at $38.7 million in Q3 2022.
  • The 5-year median for Total Liabilities is $58.2 million (2023), against an average of $57.0 million.
  • Year-over-year, Total Liabilities crashed 80.53% in 2021 and then skyrocketed 53.08% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $41.9 million in 2021, then fell by 5.4% to $39.7 million in 2022, then skyrocketed by 49.91% to $59.5 million in 2023, then rose by 29.55% to $77.0 million in 2024, then decreased by 2.42% to $75.2 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Total Liabilities are $75.2 million (Q4 2025), $78.2 million (Q3 2025), and $78.1 million (Q2 2025).